Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- How Market Research Supercharges Laboratory Diagnostics Go-To-Market Strategies April 24, 2024
- 4 Key Components to a Winning Go-To-Market Strategy April 24, 2024
- Immunoassays: A $27 Billion Market of Intrigue and Opportunity April 12, 2024
- IVD in Egypt: $440 Million Market Lead by Immunodiagnostic and Molecular Diagnostic Growth April 11, 2024
- Momentum in Multiplex Testing for IVD April 1, 2024
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Innovations in Microbiology Testing
Detection of infectious disease promptly and accurately is important because the burden of infectious disease is high. In the United States, chronic lower respiratory diseases were the third leading cause of death in 2015, behind only heart disease and cancer. The Center for Disease Control and Prevention (CDC) reports that 155,041 people died in the […]
VA – Foundation Medicine Deal a Boon for Use of Liquid Biopsy/NGS in Cancer Diagnostics
News came this week that the Department of Veterans Affairs awarded Foundation Medicine, a Cambridge, MA- based molecular testing company, a significant contract to provide genomic profiling for veterans helps to validate the growing use of NGS and liquid biopsy for diagnostics. The contract was reported to be at 111.5 million over five years. It […]
1.5 Billion Yet-Unclaimed Revenue in The LATAM IVD Market: Report
There is IVD sold almost everywhere in the world but revenue growth is not found everywhere. For most of the top IVD companies, adding scores of millions in growth would be helpful to business plans. That’s why growth regions such as Latin America offer promise beyond their market size. The maturation of IVD markets in developed countries (growth […]
New CVS Hub Stores, NASH Drugs, Liquid Biopsy, Illumina Chip, Smokeless Tobacco Reduction, Among Developments at JPM and Biotech Showcase
The 2019 J.P. Morgan Healthcare Conference (JPM) has ended. Nearly 500 companies from biotech, pharma, insurance, hospital systems and more gave investor presentations to more than 9,000 attendees at the Westin St. Francis hotel this year. The size of the conference suggests that the decision as to what the investor conference and related product showcases […]
Big Developments in DTC Testing Space
Two big developments in direct-to-consumer testing in October. While one lab giant has teamed up with a major drugstore retailer to offer consumers the ability to test themselves at portals, another has opened it’s website to online tests. We cover direct to consumer testing, routine and genetic, in our market research report on the topic. (https://www.kaloramainformation.com/Direct-Consumer-DTC-9588755/). […]
The Latest Developments in HIV Diagnostic Testing
HIV remains a deadly disease, but fortunately, in vitro diagnostic solutions abound for its detection and progress-tracking of treatments. In this article, we chronicle the developments in HIV IVD – more information can be found in our Worldwide Market for In Vitro Diagnostics Tests, 11th Edition: https://www.kaloramainformation.com/Worldwide-In-Vitro-Diagnostic-Tests-11th-Edition-11723890/ Many of the 35.3 million people infected with HIV worldwide […]
Where Clinical Sequencing Is Now
It has been little more than a year since the U.S. Food and Drug Administration (FDA) approved the first next generation sequencing (NGS) test for clinical use, and only a few months since the U.S. Centers for Medicare and Medicaid Services (CMS) announced it would provide national coverage for NGS tests for advanced cancer patients. […]
Tick-Borne Tests See Demand
When Columbia University posted a press release in February 2018 about a promising new proof-of-concept study of the Tick-Borne Disease Serochip (TBD Serochip), the press office soon had to amend the announcement with an update for the public: no, the test is not available yet; no, you can’t enroll in a clinical trial or send specimens; and no, they […]
2019 Biotech Showcase Developments of Note, with a Particular IVD Focus
From a credit card-sized clinical chemistry system to a spectrometry-based monoclonal measurement system, to phages that eat harmful bacteria, there are some interesting developments at the upcoming Biotech Showcase meeting that the Kalorama team is excited about that could directly or indirectly impact the clinical diagnostics markets. “JPM Week” will begin next week in San […]
#BIOMEDevice2018: Kalorama Presents IVD Findings, Sums Up Best Opportunities in Testing, Biosensors and AI Discussed
BIOMEDevice meeting in San Jose, CA completed its first day yesterday, with hundreds of medtech companies in attendance and exhibiting products ranging from tubing, to sensors display systems, IVD tests, plastic casing and intricate components. Kalorama presented the keynote speech at the meeting: ‘IVD: Fast Growth, Market Opportunities, New Products and Disruptive Trends’ We identified […]